Pitt Shield

Boosting often overlooked long wavelength emissions of rare-earth nanoparticles for NIR-II fluorescence imaging of orthotopic glioblastoma.

Authors: Liu Z, Ren F, Zhang H, Yuan Q, Jiang Z, Liu H, Sun Q, Li Z

Rare-earth nanoparticles (RE NPs) with narrow long wavelength emissions have been recently investigated for their potential application for fluorescence imaging in the second near-infrared window (NIR-II). Previously these RE NPs have a very limited application in the diagnosis and treatment of deep-seated tumors such as brain tumors, due to their weak fluorescence in the range of 1300-1700 nm. Herein, we report a significant enhancement of more than 10 times regular emission of NaNdF<sub>4</sub> nanoparticles at 1340 nm wavelength by coating them with an inert layer of NaLuF<sub>4</sub>, followed by sensitizing with a near-infrared dye (IR-808). We deliver these highly bright nanoparticles into the brain by using focused ultrasound to temporarily open the blood-brain barrier (BBB), and then detect the orthotopic glioblastoma by fluorescence imaging at 1340 nm. The images obtained from long wavelength fluorescence (i.e. 1340 nm) exhibited better resolution and contrast compared to the short wavelength fluorescence (i.e. 1060 nm). Our study not only provides insights for enhancing often overlooked emissions of rare-earth nanoparticles for NIR-II fluorescence imaging of deep-seated tumors, but also demonstrates great potential of focused ultrasound based technology in delivering nanotheranostic agents.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To enable FUS -mediated BBB opening for delivery of NIR-II fluorescent nanoparticles and imaging of orthotopic glioblastoma
Animal model / Human subject Nude mouse, 6-8 weeks old
Disease model glioblastoma (Orthotopic)
Targeted brain region(s) Glioblastoma; Hemisphere
Target coordinates AP: 2 mm anterior; ML: 2 mm lateral; DV: 3 mm depth
Cargo name and characteristics Rare-earth nanoparticles (rare-earth-doped nanoparticles engineered to boost long-wavelength emissions for NIR-II fluorescence imaging of orthotopic glioblastoma)
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes Enhancing long-wavelength emissions of rare-earth nanoparticles improved NIR-II fluorescence imaging of orthotopic glioblastoma, enabling brighter, deeper, and higher-contrast tumor visualization.
Safety-related matter H&E staining showed no obvious morphological differences between sonicated and untrated brain tissue, indicating no detectable tissue damage from the ultrasound instrument.

Brain Region

Ultrasound Parameters

Ultrasound instrument focused ultrasound instrument
FUS Frequency 0.5 MHz
FUS Pressure 0.6 Mpa
FUS Mode pulsed
Duration of a single FUS session 90 seconds
Focal Characteristics Focal depth: None; Focal length: None; Aperture size: 30 mm
Treatment frequency Single

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search